Download this datacard
Overview
Lobbying Costs
350,000€
Financial year: Jan 2014 - Dec 2014
Lobbyists (Full time equivalent)
1.5 Fte (3)
Lobbyists with EP accreditation
2
High-level Commission meetings
4
Lobbying Costs over the years
-
Info
Plasma Protein Therapeutics Association Europe, Association without lucrative purpose (PPTA Europe aisbl)
EU Transparency Register
687559214721-11 First registered on 20 Oct 2014
Goals / Remit
The mission of the Plasma Protein Therapeutics Association (PPTA) is to promote the availability of and access to safe and effective plasma protein therapeutics for all patients in the world. We will strive to achieve our mission by:
Fostering the collection of high-quality plasma from healthy donors;
Establishing standards for the manufacturing of life-saving plasma protein therapies at the highest levels of safety and quality;
Breaking down artificial barriers on trade and compensated donors that limit patient access to therapy;
Supporting government reimbursement practices that reflect the unique nature of plasma protein therapies;
Educating all stakeholders about the value of the therapies; and
Adhering to the PPTA Code of Ethics.Main EU files targeted
DIRECTIVE 2002/98/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 27 January 2003 setting standards of quality and safety for the collection, testing, processing, storage and distribution of human blood and blood componentsand amending Directive 2001/83/EC
DIRECTIVE 2004/23/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 31 March 2004 on setting standards of quality and safety for the donation, procurement, testing, processing, preservation, storage and distribution of human tissues and cells
Interaction with EU COM TRIS within DG GROWAddress
Head Office
Boulevard Brand Whitlock, 114
Brussels 1200
BELGIUM -
People
Total lobbyists declared
3
Employment time Lobbyists 75% 1 50% 1 25% 1 Lobbyists (Full time equivalent)
1.5
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
2 accreditations were / are live (in bold) for the selected state of 12 Jan 2017
Name Start date End Date Marilena VRANA 17 Nov 2023 15 Nov 2024 Halide TUNA 30 Sep 2023 27 Sep 2024 Rafal RAMOTOWSKI 22 Nov 2023 20 Nov 2024 Marek KORTUS 09 Nov 2023 08 Nov 2024 Evelina KOZUBOVSKA 05 Mar 2024 28 Mar 2025 Alexa WETZEL 15 Sep 2023 14 Sep 2024 Maarten VAN BAELEN 17 Nov 2023 15 Nov 2024 Ms Tuna HALIDE 28 Sep 2023 30 Sep 2023 Evelina KOZUBOVSKA 17 Mar 2023 11 Mar 2024 Rafal RAMOTOWSKI 06 Dec 2022 22 Nov 2023 Marilena VRANA 02 Dec 2022 17 Nov 2023 Maarten VAN BAELEN 28 Sep 2022 28 Sep 2023 Mr Karl Petrovsky 27 Sep 2022 30 Nov 2022 Athina Giannoutsou 24 Jun 2022 25 Feb 2023 Alexa WETZEL 24 Jun 2022 23 Jun 2023 Evelina KOZUBOVSKA 25 Mar 2022 17 Mar 2023 Mr Karl Petrovsky 07 Oct 2021 27 Sep 2022 Athina Giannoutsou 09 Jul 2021 24 Jun 2022 Alexa WETZEL 09 Jul 2021 24 Jun 2022 Maarten VAN BAELEN 09 Jul 2021 09 Jul 2022 Mr Karl Petrovsky 16 Jan 2020 16 Jan 2021 Mr Karl Petrovsky 23 Jan 2019 16 Jan 2020 Mr Karl Petrovsky 30 Jan 2018 23 Jan 2019 Mr Bruno Santoni 23 Jan 2017 20 Jan 2018 Mr Karl Petrovsky 23 Jan 2017 17 Jan 2018 Mr Bruno Santoni 02 Feb 2016 19 Jan 2017 Mr Karl Petrovsky 02 Feb 2016 19 Jan 2017 Mr Bruno Santoni 13 Feb 2015 02 Feb 2016 Mr Karl Petrovsky 13 Feb 2015 02 Feb 2016 Complementary Information
None declared
Person in charge of EU relations
Mr Karl Petrovsky (Senior Manager Health Policy Europe)
Person with legal responsibility
Mr Bruno Santoni (Executive Director, PPTA Europe)
-
Categories
Category
II - In-house lobbyists and trade/business/professional associations
Subcategory
Trade and business associations
-
Networking
Affiliation
None declared
Member organisations
None declared
-
Financial Data
Closed financial year
Jan 2014 - Dec 2014
Lobbying costs for closed financial year
350,000€
Other financial info
None declared
-
EU Structures
Groups (European Commission)
ENVI, IMCO
DG Health / Sanco
DG Growth
DG Trade
NoneACC
None
Groups (European Parliament)
None
Communication activities
http://pptaglobal.org/presentations-publications/presentations
http://pptaglobal.org/presentations-publications/publicationsOther activities
Healthcare - Pharmaceutical - Rare Diseases - Blood and blood component issues
- Meetings
Meetings
4 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
1 July 2024: We have noted that some meetings are appearing in duplicate, ie. some meetings seem to be listed twice. This seems to be because the Commission changes some element of a meeting data after the meeting has first been listed, which causes LobbyFacts to register it as a new meeting. We are investigating further.
-
Date 20 Jan 2023 Location Brussels Subject EU-US Mutual Recognition Agreement on Pharmaceutical Good Manufacturing Practices Cabinet Cabinet of Executive Vice-President Valdis Dombrovskis Portfolio An Economy that Works for People Attending - Elina Melngaile (Cabinet member)
Other Lobbyists -
Date 17 Mar 2022 Location Bruxelles Subject VTC Meeting on Blood, Tissues and Cells legislation and availability of Plasma-Derived Medicinal Products Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Karolina Herbout-Borczak (Cabinet member)
- Ralf Kuhne (Cabinet member)
-
Date 08 Apr 2021 Location online Subject Health Union Cabinet Cabinet of Vice-President Margaritis Schinas Portfolio Promoting the European Way of Life Attending - Margaritis Schinas (Vice-President)
- Catherine Sustek (Cabinet member)
Other Lobbyists -
Date 15 Jun 2018 Location Brussels, Berl Subject HTA Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Annika Nowak (Cabinet member)
- Vytenis Andriukaitis (Commissioner)
Other Lobbyists
- Meetings